{"component": "clause", "props": {"groups": [{"size": 18, "samples": [{"hash": "guhUvg0DPXx", "uri": "/contracts/guhUvg0DPXx#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}, {"hash": "f9AGe3O72sR", "uri": "/contracts/f9AGe3O72sR#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}, {"hash": "2fQhmJgB5zX", "uri": "/contracts/2fQhmJgB5zX#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}], "snippet": "Except as set forth on Schedule 3.1 attached hereto, MAS represents and warrants that:\n(a) MAS is validly existing and in good standing under the laws of the State of Texas.\n(b) the execution, delivery and authority to execute and deliver this Agreement has been duly authorized by all necessary action on the part of MAS.\n(c) MAS has the power and authority to execute and deliver this Agreement and to perform its obligations under this Agreement.\n(d) as of the date of this Agreement, it is not a party to any agreement or arrangement with any third party or under any obligation or restriction, including pursuant to its Articles of Incorporation or Bylaws, which in any way limits or conflicts with its ability to fulfill any of its obligations under this Agreement.\n(e) it is the owner of the entire right, title, and interest in and to the MAS Technology, that it has the sole right to grant licenses thereunder, and that it has not granted, and will not grant, licenses thereunder to any other entity that would restrict the rights granted to LumiCyte hereunder. MAS also further represents that there are three (3) written agreements involving the MAS Technology and that it has delivered to LumiCyte and its counsel all three of the written agreements relating to the MAS Technology (see Exhibits A, B, and C).\n(f) it is the exclusive licensee of the entire right, title, and interest in and to the Baylor Technology and the Improvements, that it has the sole right to grant sublicenses thereunder, and that it has not granted, and will not grant, sublicenses thereunder to any other entity that would restrict the rights granted to LumiCyte hereunder. MAS also further represents that there are three (3) written agreements involving the Baylor Technology and Improvements and that it has delivered to LumiCyte and its counsel all three of the written agreements relating to the Baylor Technology and Improvements (see Exhibits A, B, and C).\n(g) to the best of its knowledge, there is no action, suit, proceeding, or investigation pending or currently threatened against MAS that questions the validity of this Agreement, the rights of MAS to the Subject Technology or the right of MAS to enter into this Agreements, or to consummate the transactions contemplated hereby.\n(h) on the date hereof it is not aware of any infringement of or by the Patent Rights or any claims by any other party in and to the Subject Technology.\n(i) it is not currently in breach of the Baylor Technology Transfer Agreement, knows of no grounds for early termination of the Baylor Technology Transfer Agreement and will not breach the Baylor Technology Transfer Agreement during the term of this Agreement. Within five (5) business days of receipt of any notice from Baylor or delivery of any notice to Baylor under the Baylor Technology Transfer Agreement, it will provide a copy of such received or delivered notice to LumiCyte.\n(j) except as may be expressly set forth herein, MAS hereby disclaims and negates any and all warranties, whether express or implied, with respect to the Subject Technology or any rights hereunder transferred, including but not limited to, any IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FR ANY PARTICULAR PURPOSE. Without limiting the generality of the foregoing, MAS makes no representations or warranties as to the patentability, noninfringement, use or other application of the Subject Technology, or as to the likelihood of the success of any research, development, testing, marketing or other utilization of the Subject Technology.", "snippet_links": [{"key": "on-schedule", "type": "definition", "offset": [20, 31]}, {"key": "validly-existing", "type": "clause", "offset": [98, 114]}, {"key": "in-good-standing", "type": "definition", "offset": [119, 135]}, {"key": "the-laws", "type": "definition", "offset": [142, 150]}, {"key": "the-state-of-texas", "type": "clause", "offset": [154, 172]}, {"key": "the-execution", "type": "clause", "offset": [178, 191]}, {"key": "authority-to-execute-and-deliver", "type": "clause", "offset": [206, 238]}, {"key": "authorized-by", "type": "definition", "offset": [268, 281]}, {"key": "all-necessary-action", "type": "clause", "offset": [282, 302]}, {"key": "power-and-authority-to-execute", "type": "clause", "offset": [339, 369]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [416, 448]}, {"key": "date-of-this-agreement", "type": "definition", "offset": [464, 486]}, {"key": "a-party", "type": "clause", "offset": [498, 505]}, {"key": "agreement-or", "type": "definition", "offset": [513, 525]}, {"key": "third-party", "type": "clause", "offset": [547, 558]}, {"key": "pursuant-to", "type": "definition", "offset": [609, 620]}, {"key": "incorporation-or-bylaws", "type": "clause", "offset": [637, 660]}, {"key": "ability-to", "type": "definition", "offset": [708, 718]}, {"key": "the-owner", "type": "definition", "offset": [782, 791]}, {"key": "and-interest", "type": "clause", "offset": [820, 832]}, {"key": "mas-technology", "type": "definition", "offset": [847, 861]}, {"key": "right-to-grant-licenses", "type": "clause", "offset": [884, 907]}, {"key": "other-entity", "type": "clause", "offset": [996, 1008]}, {"key": "granted-to", "type": "definition", "offset": [1040, 1050]}, {"key": "represents-that", "type": "clause", "offset": [1088, 1103]}, {"key": "written-agreements", "type": "clause", "offset": [1124, 1142]}, {"key": "relating-to", "type": "definition", "offset": [1262, 1273]}, {"key": "see-exhibits", "type": "definition", "offset": [1294, 1306]}, {"key": "baylor-technology", "type": "definition", "offset": [1409, 1426]}, {"key": "the-improvements", "type": "clause", "offset": [1431, 1447]}, {"key": "right-to-grant-sublicenses", "type": "clause", "offset": [1470, 1496]}, {"key": "no-action", "type": "clause", "offset": [1996, 2005]}, {"key": "validity-of-this-agreement", "type": "clause", "offset": [2105, 2131]}, {"key": "rights-of", "type": "definition", "offset": [2137, 2146]}, {"key": "subject-technology", "type": "definition", "offset": [2158, 2176]}, {"key": "right-of", "type": "definition", "offset": [2184, 2192]}, {"key": "to-enter", "type": "definition", "offset": [2197, 2205]}, {"key": "contemplated-hereby", "type": "clause", "offset": [2262, 2281]}, {"key": "date-hereof", "type": "clause", "offset": [2294, 2305]}, {"key": "infringement-of", "type": "clause", "offset": [2329, 2344]}, {"key": "patent-rights", "type": "definition", "offset": [2355, 2368]}, {"key": "other-party", "type": "definition", "offset": [2390, 2401]}, {"key": "currently-in", "type": "definition", "offset": [2450, 2462]}, {"key": "breach-of", "type": "definition", "offset": [2463, 2472]}, {"key": "technology-transfer-agreement", "type": "clause", "offset": [2484, 2513]}, {"key": "termination-of-the", "type": "clause", "offset": [2545, 2563]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [2662, 2695]}, {"key": "receipt-of", "type": "clause", "offset": [2730, 2740]}, {"key": "any-notice", "type": "definition", "offset": [2741, 2751]}, {"key": "delivery-of", "type": "clause", "offset": [2767, 2778]}, {"key": "notice-to", "type": "definition", "offset": [2783, 2792]}, {"key": "a-copy-of", "type": "clause", "offset": [2864, 2873]}, {"key": "with-respect-to", "type": "clause", "offset": [3055, 3070]}, {"key": "rights-hereunder", "type": "clause", "offset": [3101, 3117]}, {"key": "not-limited", "type": "clause", "offset": [3145, 3156]}, {"key": "warranty-of-merchantability", "type": "clause", "offset": [3173, 3200]}, {"key": "particular-purpose", "type": "clause", "offset": [3219, 3237]}, {"key": "without-limiting-the-generality-of-the-foregoing", "type": "clause", "offset": [3239, 3287]}, {"key": "no-representations-or-warranties", "type": "clause", "offset": [3299, 3331]}, {"key": "application-of-the", "type": "clause", "offset": [3387, 3405]}], "hash": "d35622e43b34412f6e5de7afb15c2dd4", "id": 1}, {"size": 3, "samples": [{"hash": "guhUvg0DPXx", "uri": "/contracts/guhUvg0DPXx#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}, {"hash": "f9AGe3O72sR", "uri": "/contracts/f9AGe3O72sR#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}, {"hash": "2fQhmJgB5zX", "uri": "/contracts/2fQhmJgB5zX#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}], "snippet": "MAS represents and warrants, after due inquiry by its directors and officers, and covenants that:\n(a) It is a corporation duly organized, validly existing and in good standing under the laws of the State of Texas;\n(b) Exhibit A is a true and accurate copy of the Baylor Agreement, which has not been amended, modified or otherwise altered prior to the Execution Date; and\n(c) Exhibit D and Exhibit E are true and accurate copies of the LumiCyte Agreement and the LumiGen Agreement, respectively, prior to giving effect to the amendments set forth in Section 2.1 and Section 2.2, respectively, of the Assignment Agreement.", "snippet_links": [{"key": "due-inquiry", "type": "definition", "offset": [35, 46]}, {"key": "directors-and-officers", "type": "definition", "offset": [54, 76]}, {"key": "and-covenants", "type": "clause", "offset": [78, 91]}, {"key": "corporation-duly-organized", "type": "clause", "offset": [110, 136]}, {"key": "validly-existing", "type": "clause", "offset": [138, 154]}, {"key": "in-good-standing", "type": "definition", "offset": [159, 175]}, {"key": "the-laws", "type": "definition", "offset": [182, 190]}, {"key": "the-state-of-texas", "type": "clause", "offset": [194, 212]}, {"key": "exhibit-a", "type": "clause", "offset": [218, 227]}, {"key": "accurate-copy", "type": "clause", "offset": [242, 255]}, {"key": "baylor-agreement", "type": "definition", "offset": [263, 279]}, {"key": "execution-date", "type": "definition", "offset": [352, 366]}, {"key": "exhibit-d", "type": "definition", "offset": [376, 385]}, {"key": "exhibit-e", "type": "definition", "offset": [390, 399]}, {"key": "copies-of-the", "type": "clause", "offset": [422, 435]}, {"key": "lumicyte-agreement", "type": "definition", "offset": [436, 454]}, {"key": "lumigen-agreement", "type": "definition", "offset": [463, 480]}, {"key": "the-amendments", "type": "clause", "offset": [522, 536]}, {"key": "section-21", "type": "clause", "offset": [550, 561]}, {"key": "section-22", "type": "clause", "offset": [566, 577]}, {"key": "assignment-agreement", "type": "definition", "offset": [600, 620]}], "hash": "1dd483ac090b57a142ac9195cfbf20f9", "id": 3}, {"size": 3, "samples": [{"hash": "gcnKt9lM6Bp", "uri": "/contracts/gcnKt9lM6Bp#mas", "label": "Peer Reviewed Article", "score": 21.2539356605, "published": true}, {"hash": "gF2TSj1K9m", "uri": "/contracts/gF2TSj1K9m#mas", "label": "Peer Reviewed Article", "score": 21.2539356605, "published": true}, {"hash": "afqbvCzrqE9", "uri": "/contracts/afqbvCzrqE9#mas", "label": "Peer Reviewed Article", "score": 21.2539356605, "published": true}], "snippet": "All images assessed were reconstructed on a sharp (B60) algorithm (Siemens). All dogs had been positioned in sternal recumbency, with the limb of interest extended, ensuring there was no supination or pronation of the elbow. For each elbow three dimensional multiplanar reconstruction (MPR) views were created using OsiriX (version 5.6 32-bit, Pixmeo, Geneva) open source DICOM viewer, permitting transverse, dorsal and sagittal images to be viewed concurrently. Repeatable slice alignment was achieved by aligning slices with the caudal cortex of the ulna in the sagittal view and lateral aspect of the ulna in the dorsal view (Fig 1). Once the alignment was complete, the sagittal view was used to center the image on the most cranial part of the proximal ulna, immediately distal to the humeral condyle resulting in a repeatable standardised transverse image through the apex of the MCP. The transverse plane was chosen as the medial coronoid process is best defined in this plane (\u2587\u2587\u2587\u2587\u2587\u2587\u2587 1999). A window width of 3500 HU as previously recommended (\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 et al. 2007) and window level of 700 HU were used. A single transverse image for each elbow was archived as a JPEG file. Four board certified orthopaedic surgeons, two board certified radiologists, one diagnostic imaging resident and one surgical resident reviewed individually a single transverse CT image of the ulna at the level of the medial coronoid process from each elbow included in the study. All except one of the observers had been working together in the same institution for at least six months prior to the study. Each observer was asked to draw a line on the transverse CT image representing where, if present, they considered the junction between the normal and the sclerotic trabecular bone pattern to be delineated. This measurement was made on each transverse CT image by the eight observers twice (separated by 4 weeks). A single observer (XX) then used a sclerometer to quantify, as a percentage, the position of the observer\u2019s line demarcating the transition between normal and sclerotic trabecular bone. The use of a sclerometer was firstly reported by \u2587\u2587\u2587\u2587\u2587 et al. (2009) who applied the technique to quantify ulna sclerosis on lateral radiographs of the elbow from dogs with MCPD. Here, we applied the instrument to transverse CT images of the ulna at the level of the MCP. The sclerometer (Fig 2A) was superimposed on the image with the cranial line of the sliding scale being aligned with the most cranial cortex of the medial coronoid process of the ulna and the caudal line intersecting the most caudal cortex of the ulna. The hinged sclerometer line was then aligned with the line drawn by the observers (Fig 2B). If sclerosis was not deemed present the score was recorded to be 0%. (Fig 3) Each observers recorded whether they considered the ulna and medial coronoid process to be normal or abnormal, and they assessed images for the presence or absence of pre- determined variables (Table 1). Images were presented in a random sequence and observers did not communicate with each other. In addition to these binary variables, observers were requested to grade images using a four point ordinal grading scheme, with grade 0 representing a normal MCP and grade IV representing the MCP entirely sclerotic (Table 2). To assess intraobserver variability, each observer reviewed all CT images twice, with the same assessment criteria as in experiment 2, on occasions separated by at least four weeks. The order of the images presented to the observers was randomly assigned for the purpose of blinded image reading. \u2587\u2587\u2587\u2587\u2587\u2019\u2587 kappa (\u0199) for nominal data (experiment 2 and 3) and intraclass correlation coefficient (ICC(2,1)) for numeral values (experiment 1) were calculated to evaluate inter- and intraobserver agreement between the eight observers, and for each category of observers: surgeons (including board certified and resident), diagnostic imagers (including board certified and resident), board certified orthopaedic surgeons, board certified diagnostic imagers, board certified (including diagnostic imagers and surgeons). Interpretation of the \u0199 and the ICC value were based on \u2587\u2587\u2587\u2587\u2587\u2587 and \u2587\u2587\u2587\u2587 (1977) as shown in Table 3. 84 transverse CT images were retrieved and included in the study. Mean age was 33 months (+/- 22 months) for the clinically unaffected dogs and 44 months (+/- 38 months) for the MCPD-affected dogs. Both normal and abnormal elbows (as confirmed by history, clinical examination, CT and arthroscopy findings) were included in the study. Breed and disease status represented included Greyhound clinically unaffected, Labrador Retriever clinically unaffected and MCPD-affected Labrador Retriever. When assessing the sclerosis percentage, the interobserver agreement varied between moderate to almost perfect between groups. The intraobserver agreement was moderate to almost perfect (Table 4).", "snippet_links": [{"key": "open-source", "type": "definition", "offset": [360, 371]}, {"key": "the-mcp", "type": "definition", "offset": [882, 889]}, {"key": "transverse-plane", "type": "definition", "offset": [895, 911]}, {"key": "board-certified", "type": "definition", "offset": [1188, 1203]}, {"key": "diagnostic-imaging", "type": "definition", "offset": [1264, 1282]}, {"key": "in-the-study", "type": "clause", "offset": [1450, 1462]}, {"key": "working-together", "type": "clause", "offset": [1505, 1521]}, {"key": "six-months", "type": "definition", "offset": [1559, 1569]}, {"key": "prior-to-the", "type": "clause", "offset": [1570, 1582]}, {"key": "a-percentage", "type": "definition", "offset": [1966, 1978]}, {"key": "the-position", "type": "clause", "offset": [1980, 1992]}, {"key": "the-instrument", "type": "clause", "offset": [2285, 2299]}, {"key": "line-of", "type": "definition", "offset": [2433, 2440]}, {"key": "sliding-scale", "type": "clause", "offset": [2445, 2458]}, {"key": "the-line", "type": "definition", "offset": [2664, 2672]}, {"key": "table-1", "type": "clause", "offset": [2977, 2984]}, {"key": "in-addition-to", "type": "clause", "offset": [3081, 3095]}, {"key": "grade-iv", "type": "definition", "offset": [3247, 3255]}, {"key": "table-2", "type": "clause", "offset": [3297, 3304]}, {"key": "assessment-criteria", "type": "clause", "offset": [3402, 3421]}, {"key": "experiment-2", "type": "clause", "offset": [3428, 3440]}, {"key": "four-weeks", "type": "clause", "offset": [3477, 3487]}, {"key": "order-of", "type": "clause", "offset": [3493, 3501]}, {"key": "presented-to", "type": "definition", "offset": [3513, 3525]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [3562, 3580]}, {"key": "correlation-coefficient", "type": "definition", "offset": [3675, 3698]}, {"key": "experiment-1", "type": "clause", "offset": [3730, 3742]}, {"key": "agreement-between", "type": "clause", "offset": [3797, 3814]}, {"key": "interpretation-of-the", "type": "clause", "offset": [4119, 4140]}, {"key": "based-on", "type": "clause", "offset": [4166, 4174]}, {"key": "as-shown", "type": "definition", "offset": [4198, 4206]}, {"key": "table-3", "type": "clause", "offset": [4210, 4217]}, {"key": "clinical-examination", "type": "clause", "offset": [4475, 4495]}, {"key": "table-4", "type": "definition", "offset": [4899, 4906]}], "hash": "0508f3c5abbba2cb532d8cac6d7496e4", "id": 2}, {"size": 3, "samples": [{"hash": "guhUvg0DPXx", "uri": "/contracts/guhUvg0DPXx#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}, {"hash": "f9AGe3O72sR", "uri": "/contracts/f9AGe3O72sR#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}, {"hash": "2fQhmJgB5zX", "uri": "/contracts/2fQhmJgB5zX#mas", "label": "Settlement Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}], "snippet": "Except as set forth on Schedule 3.1 attached hereto, MAS represents and warrants that:", "snippet_links": [{"key": "on-schedule", "type": "definition", "offset": [20, 31]}], "hash": "f4a9c81e09d58b38ac82f6b5e241c203", "id": 4}, {"size": 2, "samples": [{"hash": "3kYWHsrZGtv", "uri": "/contracts/3kYWHsrZGtv#mas", "label": "Assignment Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}, {"hash": "2x4bj8ozdgI", "uri": "/contracts/2x4bj8ozdgI#mas", "label": "Assignment Agreement (Ciphergen Biosystems Inc)", "score": 21.0, "published": true}], "snippet": "MAS represents and warrants, after due inquiry by its directors and officers, and covenants that:\n(a) The execution and delivery of this Assignment Agreement has been duly authorized by all necessary action on the part of MAS (including its board of directors and shareholders, as necessary);\n(b) It has the power and authority to execute and deliver this Assignment Agreement and to perform its obligations and grant the rights granted under this Assignment Agreement;\n(c) As of the Execution Date, it is not a party to any agreement or arrangement with any Person, or to any obligation or restriction, including pursuant to its Articles of Incorporation or Bylaws, which in any way limits or conflicts with its ability to fulfill any of its obligations under this Assignment Agreement;\n(d) As of the Execution Date, MAS is not aware of any action, suit, proceeding, or investigation pending or currently threatened against MAS that questions the validity of this Assignment Agreement, or the right of MAS to enter into and deliver this Assignment Agreement, or to consummate the transactions contemplated hereby; and\n(e) As of the Effective Date, there is no MAS Assigned Technology.", "snippet_links": [{"key": "due-inquiry", "type": "definition", "offset": [35, 46]}, {"key": "directors-and-officers", "type": "definition", "offset": [54, 76]}, {"key": "and-covenants", "type": "clause", "offset": [78, 91]}, {"key": "delivery-of", "type": "clause", "offset": [120, 131]}, {"key": "assignment-agreement", "type": "definition", "offset": [137, 157]}, {"key": "authorized-by", "type": "definition", "offset": [172, 185]}, {"key": "all-necessary-action", "type": "clause", "offset": [186, 206]}, {"key": "directors-and-shareholders", "type": "clause", "offset": [250, 276]}, {"key": "authority-to-execute-and-deliver", "type": "clause", "offset": [318, 350]}, {"key": "the-rights-granted", "type": "clause", "offset": [418, 436]}, {"key": "execution-date", "type": "definition", "offset": [484, 498]}, {"key": "a-party", "type": "clause", "offset": [510, 517]}, {"key": "agreement-or", "type": "definition", "offset": [525, 537]}, {"key": "any-person", "type": "definition", "offset": [555, 565]}, {"key": "pursuant-to", "type": "definition", "offset": [614, 625]}, {"key": "incorporation-or-bylaws", "type": "clause", "offset": [642, 665]}, {"key": "ability-to", "type": "definition", "offset": [713, 723]}, {"key": "any-action", "type": "definition", "offset": [838, 848]}, {"key": "right-of", "type": "definition", "offset": [994, 1002]}, {"key": "to-enter", "type": "definition", "offset": [1007, 1015]}, {"key": "contemplated-hereby", "type": "clause", "offset": [1094, 1113]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [1123, 1147]}, {"key": "assigned-technology", "type": "clause", "offset": [1165, 1184]}], "hash": "669871eacd66e148a968c3ef38d6f406", "id": 5}, {"size": 1, "samples": [{"hash": "ltDJdroxfeV", "uri": "/contracts/ltDJdroxfeV#mas", "label": "National Master DHL Agreement", "score": 25.3805612594, "published": true}], "snippet": "place, the Local Union shall be provided with a copy of the current form(s) being used for employee evaluation for release and general job descriptions. This information shall be gener- al in nature, not employee specitic. When a modified work assignment is made, the employee shall be provided with the hours and days he/she is scheduled to work as well as the nature of the work to be performed in writing. A copy of this notice shall also be submitted to the Local Union. + An employee who is placed in a modified work position may be subject to medical evaluation(s) by a physician selected by the Employer to determine if the modified work being per- formed is accelerating the rehabilitative process as anticipated by Section 2 above. [n the event such medical evaluation(s) determine that the rehabilitative process is not being accelerat- ed, the employee shall have the right to seek a second opinion from a physician of his choosing. Any disputes regarding con- flicting medical claims shall be resolved in accordance with the provisions outlined above. The employee may be removed from the modified work program based upon final medical findings under this procedure. Employees so removed shall not have their worker's compensation benefits affected because of such removal. In the event the employee's tempo- rary disability worker's compensation benefit is subject to reduction by virtue of an applicable Federal or State statute, the Employer shall pay the difference between the amount of the reduced temporary worker's compensation benetit to which the employee would be entitled. Modified work shall be restricted to the type of work that is not expected to result in a re-injury and which can be per- formed within the medical limitations set forth by the attend- ing physician. In the event the employee, in hislher judgment, is physically unable to perform the modified work assigned, he/she shall be either reassigned modified work within his/her physical capabilities or returned to full \"temporary total\" worker's compensation benefits. In the event a third (3rd) party insurance carrier refuses to reinstate such employee to full temporary total disability benefits, the Employer shall be required to pay the difference between the amount of the ben- efit paid by such third (Jrd) party insurer and full total tempo- rary disability benetits. Determination of physical capabilities shall be based on the attending physicians medical evaluation. Under no conditions will the injured employee be required to perform work at that location subject to the terms and condi- tions of the National Agreement or its Supplements and/or Riders, provided that such employee may be required to per- form letter scanning, sorting, and re-weighing in a manner consistent with physician's restrictions. Prior to acceptance of modified work, the affected employee shall be furnished a written job description of the type of work to be performed. The modified workday and workweek shall be established by the Employer within the limitations set forth by the attending physician. However, the workday shall not exceed eight (8) hours, inclusive of coffee breaks where applicable and exclu- sive of a one-half (1/2) hour meal period and the workweek shall not exceed forty (40) hours, Monday through Friday, or Tuesday through Saturday, unless the nature of the modified work assignment requires a scheduled workweek to include Sunday. Whenever possible, the Employer will schedule \u2587\u2587\u2587\u2587 tied work during daylight hours, Monday through Friday, or during the same general working hours and on the same workweek that the employee enjoyed before he/she became injured. In the case of an employee whose workdays and/or hours routinely varied, the Employer will schedule the employee based on the availability of the modified assignment being offered. Any alleged abuse of the assignment of work- days and work hours shall be subject to the grievance proce- dure. Modified work time shall be considered as time worked when necessary to satisfy vacation and sick leave eligibility require- ments as set forth in the National Agreement, Supplements and/or Riders. In addition to earned vacation pay as set forth in the applicable Supplements and/or Riders, employees accepting \u2587\u2587\u2587\u2587 tied work shall receive prorated vacation pay for \u2587\u2587\u2587\u2587 tied work performed based on the weekly average modi tied work pay. The only time modified work is used in prorating vacation is when the employee did not qualify under the applicable Supplements and/or Riders. Holiday pay shall first be paid in accordance with the provi- sions of the applicable Supplements and/or Riders as it relates to on-the-job injuries. Once such contractual provisions have been satisfied, holidays will be paid at the modified work rate which is the modified work wage plus the temporary partial disability benetit. \u2587\u2587\u2587\u2587 leave and funeral leave taken while an employee is per- forming modified work will be paid at the modi tied work rate, which is the modified work wage plus the temporary partial dis- ability benefit. Unused sick leave will be paid at the applicable contract rate where the employee performed modified work and qualified for the sick leave during the contract year. The Employer shall continue to remit contributions to the appropriate Health & Welfare and Pension trusts during the entire time period employees are performing modified work. The payment of Health & Welfare and Pension contributions while the employee is on modified work is not included in the Health & Welfare and Pension contributions required by the Supplement when an employee is off work on worker's com- pensation. Continuation of such contributions beyond the period of time specified in the Supplements and/or Riders for on-the-job injury shall be required. Provisions of this Section shall not be utilized as a reason to disqualify or remove an employee from the modified work program. Employees accepting modi tied work shall receive temporary partial benefits as determined by each respective state worker's compensation law, plus a modified work wage when added to such temporary partial benefit, shalt equal not less than eighty- live percent (85%) of forty (40) hours pay he/she would other- wise be entitled to under the provisions of the applicable Supplements and/or Riders for the tirst six (6) months from the date the moditied work assignment commences. After this ini- tial six (6) month period, the percentage shall increase to ninety percent (90%) for the duration of each individual modi tied work assignment. The Employer shall not refuse to assign moditied work to employees based solely on such employees reaching the ninety percent (90%) wage level. Such refusal shall be consid- ered an abuse of the program and shall be subject to the griev- ance procedure. Moditied work assignments beginning or end- ing within a workweek shall be paid on a prorated basis; one (I) day equals one-tifth (1/5th). Employees accepting modi tied work shall not be subject to disciplinary action provisions of the Operational Supplements, Regional Supplements and/or Local Riders unless such \u2587\u2587\u2587\u2587\u2587- tion involves an offense for which no prior warning notice is required under the applicable Supplement or Rider (Cardinal Sins). Additionally, the Uniform Testing Procedures set forth in the National Agreement shall apply. -t Alleged abuses of the modified work program by the Employer and any factual grievance or request for interpretation concern- ing this Article shall be submitted directly to the Regional Joint Area Committee. Proven abuses may result in a determination by the National Grievance Committee that would withdraw the benefits of this Article from that Employer, in whole or in part, in which case affected employees shall immediately revert to full worker's compensation benefits.\nSection 3. Americans with Disabilities Act The Union and the Employer recognize their obligations under the Americans with Disabilities Act. It is agreed that the Employer shall determine whether an employee is a qualified individual with a disability under the ADA and, if so, what reasonable accommodations, if any, should be provided. In the event that the Employer determines that a reasonable accommodation is necessary, the Employer shall notify the Local Union before providing the reasonable accommodation to a qualitied bargaining unit employee to ensure that the rea- sonable accommodation selected by the Employer does not impact another employee's seniority or other contract rights. Any dispute over whether the Employer complied with its duty to notify the Local Union before implementing a proposed rea- sonable accommodation or whether providing the reasonable accommodation violates any employee's rights under any other provision of the National Agreement shall be subject to the grievance procedure. Disputes over whether the Employer has complied with its legal requirements under the ADA, including the ADA requirements to provide a reasonable accommodation, however, shall not be subject to the grievance procedure.", "snippet_links": [{"key": "local-union", "type": "definition", "offset": [11, 22]}, {"key": "the-current", "type": "clause", "offset": [56, 67]}, {"key": "employee-evaluation", "type": "clause", "offset": [91, 110]}, {"key": "general-job-descriptions", "type": "clause", "offset": [127, 151]}, {"key": "not-employee", "type": "clause", "offset": [200, 212]}, {"key": "modified-work-assignment", "type": "clause", "offset": [230, 254]}, {"key": "the-employee-shall", "type": "clause", "offset": [264, 282]}, {"key": "scheduled-to-work", "type": "definition", "offset": [329, 346]}, {"key": "nature-of-the-work", "type": "clause", "offset": [362, 380]}, {"key": "in-writing", "type": "clause", "offset": [397, 407]}, {"key": "an-employee-who", "type": "clause", "offset": [477, 492]}, {"key": "work-position", "type": "clause", "offset": [517, 530]}, {"key": "medical-evaluation", "type": "definition", "offset": [549, 567]}, {"key": "by-the-employer", "type": "clause", "offset": [595, 610]}, {"key": "to-determine", "type": "definition", "offset": [611, 623]}, {"key": "section-2", "type": "definition", "offset": [724, 733]}, {"key": "right-to", "type": "definition", "offset": [879, 887]}, {"key": "second-opinion", "type": "definition", "offset": [895, 909]}, {"key": "disputes-regarding", "type": "clause", "offset": [948, 966]}, {"key": "medical-claims", "type": "clause", "offset": [981, 995]}, {"key": "in-accordance-with", "type": "definition", "offset": [1014, 1032]}, {"key": "modified-work-program", "type": "clause", "offset": [1101, 1122]}, {"key": "compensation-benefits", "type": "clause", "offset": [1230, 1251]}, {"key": "in-the-event-the", "type": "clause", "offset": [1286, 1302]}, {"key": "state-statute", "type": "definition", "offset": [1429, 1442]}, {"key": "the-employer-shall", "type": "clause", "offset": [1444, 1462]}, {"key": "temporary-worker", "type": "definition", "offset": [1516, 1532]}, {"key": "injury-and", "type": "clause", "offset": [1690, 1700]}, {"key": "medical-limitations", "type": "clause", "offset": [1737, 1756]}, {"key": "physical-capabilities", "type": "clause", "offset": [1968, 1989]}, {"key": "insurance-carrier", "type": "clause", "offset": [2093, 2110]}, {"key": "to-reinstate", "type": "clause", "offset": [2119, 2131]}, {"key": "total-disability-benefits", "type": "definition", "offset": [2164, 2189]}, {"key": "to-pay", "type": "clause", "offset": [2222, 2228]}, {"key": "determination-of", "type": "clause", "offset": [2367, 2383]}, {"key": "based-on", "type": "clause", "offset": [2415, 2423]}, {"key": "no-conditions", "type": "clause", "offset": [2475, 2488]}, {"key": "injured-employee", "type": "clause", "offset": [2498, 2514]}, {"key": "terms-and", "type": "clause", "offset": [2575, 2584]}, {"key": "agreement-or", "type": "definition", "offset": [2614, 2626]}, {"key": "provided-that", "type": "clause", "offset": [2658, 2671]}, {"key": "form-letter", "type": "clause", "offset": [2710, 2721]}, {"key": "weighing-in", "type": "definition", "offset": [2748, 2759]}, {"key": "consistent-with", "type": "clause", "offset": [2769, 2784]}, {"key": "acceptance-of", "type": "definition", "offset": [2820, 2833]}, {"key": "description-of-the", "type": "definition", "offset": [2904, 2922]}, {"key": "type-of-work-to-be-performed", "type": "clause", "offset": [2923, 2951]}, {"key": "workday-and-workweek", "type": "clause", "offset": [2966, 2986]}, {"key": "attending-physician", "type": "definition", "offset": [3064, 3083]}, {"key": "the-workday", "type": "clause", "offset": [3094, 3105]}, {"key": "inclusive-of", "type": "clause", "offset": [3140, 3152]}, {"key": "coffee-breaks", "type": "clause", "offset": [3153, 3166]}, {"key": "where-applicable", "type": "clause", "offset": [3167, 3183]}, {"key": "meal-period", "type": "clause", "offset": [3225, 3236]}, {"key": "the-workweek", "type": "clause", "offset": [3241, 3253]}, {"key": "monday-through-friday", "type": "clause", "offset": [3289, 3310]}, {"key": "scheduled-workweek", "type": "clause", "offset": [3402, 3420]}, {"key": "whenever-possible", "type": "clause", "offset": [3440, 3457]}, {"key": "the-employer-will", "type": "clause", "offset": [3459, 3476]}, {"key": "daylight-hours", "type": "definition", "offset": [3508, 3522]}, {"key": "general-working-hours", "type": "clause", "offset": [3566, 3587]}, {"key": "in-the-case-of-an", "type": "clause", "offset": [3669, 3686]}, {"key": "availability-of", "type": "clause", "offset": [3795, 3810]}, {"key": "alleged-abuse", "type": "definition", "offset": [3854, 3867]}, {"key": "assignment-of", "type": "definition", "offset": [3875, 3888]}, {"key": "work-hours", "type": "definition", "offset": [3904, 3914]}, {"key": "work-time", "type": "clause", "offset": [3971, 3980]}, {"key": "time-worked", "type": "definition", "offset": [4004, 4015]}, {"key": "sick-leave-eligibility", "type": "clause", "offset": [4055, 4077]}, {"key": "in-addition-to", "type": "clause", "offset": [4160, 4174]}, {"key": "earned-vacation-pay", "type": "clause", "offset": [4175, 4194]}, {"key": "the-applicable", "type": "clause", "offset": [4211, 4225]}, {"key": "for-\u2587", "type": "clause", "offset": [4324, 4329]}, {"key": "work-performed", "type": "definition", "offset": [4338, 4352]}, {"key": "weekly-average", "type": "definition", "offset": [4366, 4380]}, {"key": "holiday-pay", "type": "clause", "offset": [4544, 4555]}, {"key": "relates-to", "type": "definition", "offset": [4662, 4672]}, {"key": "contractual-provisions", "type": "clause", "offset": [4704, 4726]}, {"key": "temporary-partial-disability", "type": "definition", "offset": [4837, 4865]}, {"key": "funeral-leave", "type": "clause", "offset": [4890, 4903]}, {"key": "unused-sick-leave", "type": "clause", "offset": [5080, 5097]}, {"key": "applicable-contract-rate", "type": "definition", "offset": [5118, 5142]}, {"key": "where-the-employee", "type": "clause", "offset": [5143, 5161]}, {"key": "work-and", "type": "clause", "offset": [5181, 5189]}, {"key": "the-sick-leave", "type": "clause", "offset": [5204, 5218]}, {"key": "contract-year", "type": "definition", "offset": [5230, 5243]}, {"key": "contributions-to", "type": "clause", "offset": [5282, 5298]}, {"key": "pension-trusts", "type": "clause", "offset": [5336, 5350]}, {"key": "time-period", "type": "definition", "offset": [5369, 5380]}, {"key": "payment-of", "type": "definition", "offset": [5425, 5435]}, {"key": "pension-contributions", "type": "clause", "offset": [5457, 5478]}, {"key": "not-included", "type": "clause", "offset": [5521, 5533]}, {"key": "required-by", "type": "definition", "offset": [5584, 5595]}, {"key": "when-an-employee", "type": "clause", "offset": [5611, 5627]}, {"key": "work-on", "type": "definition", "offset": [5635, 5642]}, {"key": "continuation-of", "type": "clause", "offset": [5668, 5683]}, {"key": "period-of-time", "type": "clause", "offset": [5714, 5728]}, {"key": "the-supplements", "type": "clause", "offset": [5742, 5757]}, {"key": "job-injury", "type": "clause", "offset": [5783, 5793]}, {"key": "provisions-of-this-section", "type": "clause", "offset": [5813, 5839]}, {"key": "state-worker", "type": "definition", "offset": [6051, 6063]}, {"key": "compensation-law", "type": "clause", "offset": [6066, 6082]}, {"key": "the-provisions-of-the", "type": "clause", "offset": [6279, 6300]}, {"key": "the-percentage", "type": "definition", "offset": [6464, 6478]}, {"key": "duration-of", "type": "definition", "offset": [6526, 6537]}, {"key": "the-program", "type": "clause", "offset": [6772, 6783]}, {"key": "work-assignments", "type": "definition", "offset": [6844, 6860]}, {"key": "disciplinary-action", "type": "clause", "offset": [7033, 7052]}, {"key": "warning-notice", "type": "clause", "offset": [7200, 7214]}, {"key": "applicable-supplement", "type": "definition", "offset": [7237, 7258]}, {"key": "testing-procedures", "type": "clause", "offset": [7311, 7329]}, {"key": "request-for-interpretation", "type": "definition", "offset": [7471, 7497]}, {"key": "this-article", "type": "definition", "offset": [7511, 7523]}, {"key": "joint-area-committee", "type": "clause", "offset": [7568, 7588]}, {"key": "national-grievance-committee", "type": "clause", "offset": [7641, 7669]}, {"key": "benefits-of-this", "type": "clause", "offset": [7694, 7710]}, {"key": "employees-shall", "type": "clause", "offset": [7783, 7798]}, {"key": "section-3", "type": "clause", "offset": [7858, 7867]}, {"key": "the-union-and-the-employer", "type": "clause", "offset": [7901, 7927]}, {"key": "the-americans-with-disabilities-act", "type": "clause", "offset": [7962, 7997]}, {"key": "it-is-agreed-that", "type": "clause", "offset": [7999, 8016]}, {"key": "determine-whether", "type": "clause", "offset": [8036, 8053]}, {"key": "a-qualified-individual-with-a-disability", "type": "definition", "offset": [8069, 8109]}, {"key": "reasonable-accommodations", "type": "clause", "offset": [8141, 8166]}, {"key": "notify-the", "type": "clause", "offset": [8303, 8313]}, {"key": "providing-the", "type": "clause", "offset": [8333, 8346]}, {"key": "bargaining-unit-employee", "type": "definition", "offset": [8387, 8411]}, {"key": "to-ensure", "type": "clause", "offset": [8412, 8421]}, {"key": "other-contract-rights", "type": "clause", "offset": [8531, 8552]}, {"key": "duty-to-notify", "type": "definition", "offset": [8610, 8624]}, {"key": "a-proposed", "type": "clause", "offset": [8661, 8671]}, {"key": "any-employee", "type": "clause", "offset": [8758, 8770]}, {"key": "provision-of-the", "type": "clause", "offset": [8796, 8812]}, {"key": "the-grievance-procedure", "type": "clause", "offset": [8852, 8875]}, {"key": "disputes-over", "type": "clause", "offset": [8877, 8890]}, {"key": "legal-requirements", "type": "clause", "offset": [8934, 8952]}, {"key": "ada-requirements", "type": "definition", "offset": [8982, 8998]}, {"key": "provide-a", "type": "definition", "offset": [9002, 9011]}], "hash": "22098855954236d46639bccb34283a53", "id": 6}, {"size": 1, "samples": [{"hash": "95zzEau6WHj", "uri": "/contracts/95zzEau6WHj#mas", "label": "End User Agreement", "score": 25.3312799452, "published": true}], "snippet": "The data used here are therefore insufficient to provide a full analysis of how the scan dose affects the outcome of our system. However, we believe it is likely that using data with a better signal-to-noise ratio would improve the system results. Nonetheless, it is advantageous to have shown that the system is also capable of working on low-dose data which can be acquired with less risk to the subject.", "snippet_links": [{"key": "the-data", "type": "clause", "offset": [0, 8]}, {"key": "provide-a", "type": "definition", "offset": [49, 58]}, {"key": "our-system", "type": "definition", "offset": [117, 127]}, {"key": "we-believe", "type": "clause", "offset": [138, 148]}, {"key": "is-likely", "type": "definition", "offset": [152, 161]}, {"key": "the-system", "type": "definition", "offset": [228, 238]}, {"key": "capable-of", "type": "definition", "offset": [318, 328]}, {"key": "the-subject", "type": "clause", "offset": [394, 405]}], "hash": "286d7c9286dfdda6bc846d57ba518d20", "id": 7}, {"size": 1, "samples": [{"hash": "m2dmGlV2r1", "uri": "/contracts/m2dmGlV2r1#mas", "label": "Class Action Settlement Agreement", "score": 29.7085819735, "published": true}], "snippet": "\u2587\u2587\u2587 Corporation, San Mateo Superior Court Action No. 535413 (the \u201cSecond Related Case\u201d);", "snippet_links": [{"key": "san-mateo", "type": "definition", "offset": [17, 26]}, {"key": "court-action", "type": "clause", "offset": [36, 48]}, {"key": "related-case", "type": "definition", "offset": [73, 85]}], "hash": "dc62e8e5fa1c79244fa9b221fc2f3522", "id": 8}, {"size": 1, "samples": [{"hash": "8erdIW9RNU5", "uri": "/contracts/8erdIW9RNU5#mas", "label": "Software Development and Processing Services Agreement (Prodigy Communications Inc)", "score": 18.0, "published": true}], "snippet": "The MAS System developed by FDRI pursuant to this Agreement shall be the sole and exclusive property of FDRI, and, subject to any rights PRODIGY may have to license such System pursuant to this Agreement, PRODIGY acknowledges and agrees that all rights, title and interests in and to the MAS System, including, without limitation maskworks, firmware, computer programs, algorithms, subroutines, methods, concepts, designs, know-how, techniques, data or other information of or concerning the MAS System Contract #3284 are and shall remain the sole and exclusive property of FDRI; provided, however, that all Confidential Information of PRODIGY used by FDRI to develop the MAS System shall be subject to the Confidentiality Agreement between the parties dated August 8, 1991; and provided, further, that during the Original Term and any Renewal Period, FDRI shall not license or sell the MAS System, including any modules or subsystems of the MAS System, nor use the MAS System, or any modules or subsystems thereof, to provide data processing services to any third party that is a direct competitor of PRODIGY in a line of business provided on a commercial basis by PRODIGY, whether on-line or otherwise, domestically or internationally. Except for any patent, copyright, trademark or other proprietary right retained by PRODIGY in any Confidential Information of PRODIGY disclosed to FDRI under the terms of the above-referenced Confidentiality Agreement and used by FDRI to develop the MAS System, FDRI shall be the exclusive owner of all copyrights, patents, patent application rights, corporate name and trademarks embodied in or applicable to or noted in the MAS System or any components or subsystems thereof. In the event of a conflict between this subsection 1.1.8.2(a)(ii) and any provision of the above-referenced Contract #3284 Confidentiality Agreement, the language contained herein shall prevail.", "snippet_links": [{"key": "pursuant-to-this-agreement", "type": "clause", "offset": [33, 59]}, {"key": "sole-and-exclusive-property", "type": "clause", "offset": [73, 100]}, {"key": "all-rights", "type": "clause", "offset": [242, 252]}, {"key": "without-limitation", "type": "clause", "offset": [311, 329]}, {"key": "computer-programs", "type": "definition", "offset": [351, 368]}, {"key": "other-information", "type": "definition", "offset": [453, 470]}, {"key": "concerning-the", "type": "clause", "offset": [477, 491]}, {"key": "system-contract", "type": "definition", "offset": [496, 511]}, {"key": "confidential-information-of", "type": "clause", "offset": [608, 635]}, {"key": "to-develop", "type": "definition", "offset": [657, 667]}, {"key": "agreement-between-the-parties", "type": "clause", "offset": [723, 752]}, {"key": "during-the-original-term", "type": "clause", "offset": [803, 827]}, {"key": "renewal-period", "type": "definition", "offset": [836, 850]}, {"key": "to-provide", "type": "definition", "offset": [1016, 1026]}, {"key": "data-processing-services", "type": "definition", "offset": [1027, 1051]}, {"key": "third-party", "type": "clause", "offset": [1059, 1070]}, {"key": "direct-competitor", "type": "clause", "offset": [1081, 1098]}, {"key": "line-of-business", "type": "definition", "offset": [1115, 1131]}, {"key": "on-a-commercial-basis", "type": "definition", "offset": [1141, 1162]}, {"key": "proprietary-right", "type": "definition", "offset": [1291, 1308]}, {"key": "any-confidential-information", "type": "clause", "offset": [1332, 1360]}, {"key": "terms-of-the", "type": "clause", "offset": [1400, 1412]}, {"key": "patent-application", "type": "clause", "offset": [1562, 1580]}, {"key": "name-and-trademarks", "type": "clause", "offset": [1599, 1618]}, {"key": "applicable-to", "type": "clause", "offset": [1634, 1647]}, {"key": "in-the-event-of-a", "type": "clause", "offset": [1716, 1733]}, {"key": "this-subsection", "type": "definition", "offset": [1751, 1766]}, {"key": "provision-of-the", "type": "clause", "offset": [1790, 1806]}], "hash": "cd12c7a537994579ce08ae8d7e066463", "id": 9}, {"size": 1, "samples": [{"hash": "4TJwO1licff", "uri": "/contracts/4TJwO1licff#mas", "label": "Contract for the Supply of International Trade Services", "score": 22.1937029432, "published": true}], "snippet": "It will be specific to the needs of each company. ITAs will continue to supply advice, support and access through UKTI\u2019s overseas network and through UKTI services such as OMIS, ECR and EMRS. Eligible companies are innovative and have between 2 and 10 years experience of exporting. Their needs are therefore likely to be more complex than those of P2E companies. No more than a third of Gateway to Global Growth clients are likely to be companies that have previously benefited from the P2E scheme. This is largely a Regional ITT delivered programme with support from the Regional Director's team. The Regional ITT will be responsible for: recruiting participants; organising training and master classes and booking participants; taking clients through the support process including action planning; and", "snippet_links": [{"key": "be-specific", "type": "clause", "offset": [8, 19]}, {"key": "support-and-access", "type": "clause", "offset": [87, 105]}, {"key": "years-experience", "type": "clause", "offset": [252, 268]}, {"key": "regional-director", "type": "definition", "offset": [573, 590]}, {"key": "responsible-for", "type": "clause", "offset": [624, 639]}, {"key": "support-process", "type": "clause", "offset": [758, 773]}, {"key": "action-planning", "type": "clause", "offset": [784, 799]}], "hash": "f3bfbb9089a8d03aae8414afc6ab9fc5", "id": 10}], "next_curs": "CkwSRmoVc35sYXdpbnNpZGVyY29udHJhY3RzcigLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IgxtYXMjMDAwMDAwMGEMogECZW4YACAA", "clause": {"size": 17, "title": "MAS", "children": [], "parents": [["warranties-and-representations", "Warranties and Representations"], ["warranties-and-representation", "Warranties and Representation"], ["certain-representations-and-warranties", "Certain Representations and Warranties"], ["miscellaneous", "Miscellaneous"], ["usury-savings", "Usury Savings"]], "id": "mas", "related": [["meminta-nasihat", "meminta nasihat", "meminta nasihat"], ["conhecimento-da-lingua", "Conhecimento da Lingua", "Conhecimento da Lingua"], ["lokasi-\u2587\u2587\u2587-keterangan-hartanah", "LOKASI \u2587\u2587\u2587 KETERANGAN HARTANAH", "LOKASI \u2587\u2587\u2587 KETERANGAN HARTANAH"], ["du\u0161evn\u00ed-vlastnictv\u00ed", "DU\u0160EVN\u00cd VLASTNICTV\u00cd", "DU\u0160EVN\u00cd VLASTNICTV\u00cd"], ["wsib-ltd", "WSIB & LTD", "WSIB & LTD"]], "related_snippets": [], "updated": "2025-07-07T12:37:48+00:00", "also_ask": ["What are the essential elements that must be included in a MAS clause to ensure enforceability?", "How can a MAS clause be strategically negotiated to limit or expand its scope for the client\u2019s benefit?", "What are the most common risks or pitfalls associated with poorly drafted MAS clauses?", "How do MAS clauses compare to similar provisions in other jurisdictions or under different governing laws?", "What factors do courts typically consider when determining the enforceability of a MAS clause?"], "drafting_tip": "Define 'MAS' explicitly to avoid ambiguity; specify its regulatory role to clarify obligations; reference relevant MAS guidelines to ensure compliance.", "explanation": "The MAS (Master Agreement Schedule) clause serves as a supplementary document to a master agreement, outlining specific terms, conditions, and variables that apply to the parties\u2019 contractual relationship. It typically details items such as payment terms, product specifications, delivery schedules, or other negotiated provisions that are unique to the transaction or parties involved. By consolidating these particulars in a schedule, the clause ensures that the master agreement remains flexible and adaptable, allowing for clear customization without altering the core contract, thereby promoting clarity and efficiency in contract administration."}, "json": true, "cursor": ""}}